Predictive and prognostic clinical and pathological factors of nivolumab efficacy in non-small-cell lung cancer patients (vol 20, pg 1072, 2018)

被引：1

作者：

Garde-Noguera, J. ^{[1
]}

Martin-Martorell, P. ^{[2
]}

De Julian, M. ^{[3
]}

Perez-Altozano, J. ^{[4
]}

Salvador-Coloma, C. ^{[5
]}

Garcia-Sanchez, J. ^{[1
]}

Insa-Molla, A. ^{[2
]}

Martin, M. ^{[6
]}

Mielgo-Rubio, X. ^{[7
]}

Marin-Liebana, S. ^{[8
]}

Blasco-Cordellat, A.

Blasco-Molla, S. ^{[9
,10
]}

Girones, R. ^{[11
]}

Marquez-Medina, D. ^{[12
]}

Aparisi, F. ^{[13
]}

Bas Cerda, M. C. ^{[14
]}

Macia-Escalante, S. ^{[15
]}

Sanchez, A. ^{[3
]}

Juan-Vidal, O. ^{[5
]}

机构：

[1] Hosp Arnau Vilanova, C St Climent 12, Valencia 46015, Spain

[2] Univ Hosp Clin Valencia, Valencia, Spain

[3] Hosp Prov Castellon, Castellon de La Plana, Spain

[4] Hosp Gen Elche, Elche, Spain

[5] Hosp Univ Politecn La Fe, Valencia, Spain

[6] Hosp Dr Peset, Valencia, Spain

[7] Hosp Univ Fdn Alcorcon, Alcorcon, Spain

[8] Hosp Manises, Manises, Spain

[9] Hosp Gen Univ Valencia, Valencia, Spain

[10] Hosp Sagunto, Sagunto, Spain

[11] Hosp Lluis Alcanyis, Xativa, Spain

[12] Hosp Arnau Vilanova, Lleida, Spain

[13] Hosp Virgen Lirios, Alcoy, Spain

[14] Univ Politecn Valencia, Valencia, Spain

[15] Pivotal CRO, Madrid, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2018年 / 20卷 / 08期

关键词：

GIDO; Immunotherapy; Nivolumab; Non-small-cell lung cancer;

D O I：

10.1007/s12094-018-1916-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Clinical and Translational Oncology.

引用

页码：1096 / 1096

页数：1